[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AU5315000A - Indicators for monitoring the technique of transcutaneous immunization - Google Patents

Indicators for monitoring the technique of transcutaneous immunization

Info

Publication number
AU5315000A
AU5315000A AU53150/00A AU5315000A AU5315000A AU 5315000 A AU5315000 A AU 5315000A AU 53150/00 A AU53150/00 A AU 53150/00A AU 5315000 A AU5315000 A AU 5315000A AU 5315000 A AU5315000 A AU 5315000A
Authority
AU
Australia
Prior art keywords
indicators
monitoring
technique
transcutaneous immunization
transcutaneous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU53150/00A
Inventor
Gregory M. Glenn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU5315000A publication Critical patent/AU5315000A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nanotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
AU53150/00A 1999-06-03 2000-06-02 Indicators for monitoring the technique of transcutaneous immunization Abandoned AU5315000A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13779099P 1999-06-03 1999-06-03
US60137790 1999-06-03
PCT/US2000/015183 WO2000074714A2 (en) 1999-06-03 2000-06-02 Indicators for monitoring the technique of transcutaneous immunization

Publications (1)

Publication Number Publication Date
AU5315000A true AU5315000A (en) 2000-12-28

Family

ID=22479050

Family Applications (1)

Application Number Title Priority Date Filing Date
AU53150/00A Abandoned AU5315000A (en) 1999-06-03 2000-06-02 Indicators for monitoring the technique of transcutaneous immunization

Country Status (2)

Country Link
AU (1) AU5315000A (en)
WO (1) WO2000074714A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060002949A1 (en) 1996-11-14 2006-01-05 Army Govt. Of The Usa, As Rep. By Secretary Of The Office Of The Command Judge Advocate, Hq Usamrmc. Transcutaneous immunization without heterologous adjuvant
JP2004525921A (en) * 2001-03-19 2004-08-26 イオマイ コーポレイシヨン Transdermal immunization patch
DE102004001558A1 (en) * 2004-01-10 2005-08-18 Bayer Healthcare Ag Medicinal products for topical application in animals

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1600332A (en) * 1968-12-31 1970-07-20
AR215459A1 (en) * 1976-04-02 1979-10-15 Brewer J METHOD TO PRODUCE A THERAPEUTIC AGENT CAPABLE OF PROVIDING A MARK ON A NON-HUMAN ANIMAL TO INDICATE THE ADMINISTRATION OF THE AGENT TO THE ANIMAL AND TO ALSO PROVIDE A REPOSITORY OF THE AGENT TO BE RELEASED DURING A SPACE OF TIME
US5466465A (en) * 1993-12-30 1995-11-14 Harrogate Holdings, Limited Transdermal drug delivery system
US5980898A (en) * 1996-11-14 1999-11-09 The United States Of America As Represented By The U.S. Army Medical Research & Material Command Adjuvant for transcutaneous immunization

Also Published As

Publication number Publication date
WO2000074714A2 (en) 2000-12-14
WO2000074714A3 (en) 2001-07-05

Similar Documents

Publication Publication Date Title
AU1219501A (en) Alertness monitoring system
AU5988800A (en) System for ecg monitoring
AU7998900A (en) Automotive-ceiling-mounted monitor
AU2955200A (en) Cannula
AU4094599A (en) Patient monitoring apparatus
AU1445301A (en) Hygiene monitoring system
AUPQ966600A0 (en) System for physiological monitoring during sleep
AU7902400A (en) Method for the preparation of 5-carboxyphthalide
AU1453901A (en) Adverse drug event monitoring
AU2002212960A1 (en) Diagnostic system for monitoring physiological conditions
AU5831500A (en) Process for the preparation of polyols
AU2376001A (en) Method for the manufacture of olefins
AU1163101A (en) Diagnostic methods
AUPQ081899A0 (en) Anchoring system
AU2254301A (en) Monitoring seal system
AU5550000A (en) Monitoring system
AU1160101A (en) Monitoring apparatus
AU5315000A (en) Indicators for monitoring the technique of transcutaneous immunization
AU4607500A (en) Monitoring system
AU2829700A (en) Processes for the preparation of alpha-aminoketones
AU4416500A (en) Tomographic system
AU1130901A (en) Method for the preparation of 5-carboxyphthalide
AU2194801A (en) Diagnostic method
AU6000600A (en) Diagnostic method
AU4755800A (en) Diagnostic system

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase